Tiziana Life Sciences PLC (NASDAQ:TLSA)

6.50
Delayed Data
As of 3:50pm ET
 +0.23 / +3.67%
Today’s Change
1.54
Today|||52-Week Range
7.70
+140.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$184.5M

Company Description

Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.

Contact Information

Tiziana Life Sciences Plc
55 Park Lane
London Greater London W1K 1NA
P:442074952379
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

There are no executives to display.